voluntary recall of this med. a little bit confused@
Losartan Recall Expanded Due to Potential Carcinogen. On April 18, the FDA issued a voluntary national recall of Losartan Potassium tablets, USP and Losartan Potassium/Hydrochlorothiazide tablets, USP.Apr 23, 2019
-
-
-
Only by some manufacturers
End of conversation
New conversation -
-
-
Adding the blood-pressure drug losartan to the protocol for treating locally advanced pancreatic cancer improved patient survival in a MGH News clinical trial.



Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.